(Q44883020)

7 December 2017

title

Neutral endopeptidase 24.11 is important for the degradation of both endogenous and exogenous glucagon in anesthetized pigs (English)

1 reference

7 December 2017

1 reference

4

1 reference

7 December 2017

Ramona Trebbien

1

0 references

Carolyn F. Deacon

object named as

Carolyn F Deacon

6

0 references

author name string

Letty Klarskov

2

1 reference

7 December 2017

Mette Olesen

3

1 reference

7 December 2017

Richard D Carr

5

1 reference

7 December 2017

language of work or name

1 reference

4 May 2004

1 reference

American Journal of Physiology - Endocrinology and Metabolism

7 December 2017

published in

1 reference

7 December 2017

volume

287

1 reference

7 December 2017

issue

3

1 reference

7 December 2017

page(s)

E431-8

1 reference

Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Differential regional metabolism of glucagon in anesthetized pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Glucagon metabolism in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

An immunoradiometric assay for endopeptidase-24.11 shows it to be a widely distributed enzyme in pig tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Evidence that glicentin contains the entire sequence of glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Structure-function relations in glucagon. Properties of highly purified Des-his1-, monoiodo-, and [Des-Asn28,Thr29](homoserine lactone27)-glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Metabolism of glucagon by dipeptidyl peptidase IV (CD26).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Persistent effect of sustained hyperglucagonemia on glucose production in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Evanescent effects of hypo- and hyperglucagonemia on blood glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

Effects of amino acids and glucagon on renal hemodynamics in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00353.2003

10.1152/AJPENDO.00353.2003

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference